Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-13-222369
Filing Date
2013-05-15
Accepted
2013-05-15 16:12:43
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d521399d10q.htm 10-Q 377799
2 EX-31.1 d521399dex311.htm EX-31.1 9997
3 EX-31.2 d521399dex312.htm EX-31.2 9979
4 EX-32.1 d521399dex321.htm EX-32.1 6152
11 GRAPHIC g521399pic-001.jpg GRAPHIC 12400
  Complete submission text file 0001193125-13-222369.txt   2083384

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vrml-20130331.xml EX-101.INS 139451
6 XBRL TAXONOMY EXTENSION SCHEMA vrml-20130331.xsd EX-101.SCH 27042
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vrml-20130331_cal.xml EX-101.CAL 37081
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vrml-20130331_def.xml EX-101.DEF 150784
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vrml-20130331_lab.xml EX-101.LAB 216945
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vrml-20130331_pre.xml EX-101.PRE 173677
Mailing Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING TWO SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

IRS No.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34810 | Film No.: 13847161
SIC: 2835 In Vitro & In Vivo Diagnostic Substances